<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Community:</title>
  <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/254" />
  <subtitle />
  <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/254</id>
  <updated>2026-04-27T19:00:15Z</updated>
  <dc:date>2026-04-27T19:00:15Z</dc:date>
  <entry>
    <title>Synthesis, Characterization and Biological Evaluation of Ethyl-4'-(cyclopropane carboxamido-N-yl)-5-ary-3-oxo-3,4,5,6- tetrahydro-biphenyl-4-carboxylate</title>
    <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/2205" />
    <author>
      <name>Akbari, P.M</name>
    </author>
    <author>
      <name>Shah, V.R.</name>
    </author>
    <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/2205</id>
    <updated>2025-01-01T11:26:08Z</updated>
    <published>2019-01-01T00:00:00Z</published>
    <summary type="text">Title: Synthesis, Characterization and Biological Evaluation of Ethyl-4'-(cyclopropane carboxamido-N-yl)-5-ary-3-oxo-3,4,5,6- tetrahydro-biphenyl-4-carboxylate
Authors: Akbari, P.M; Shah, V.R.
Abstract: A series of new substituted cyclohexenone derivatives have been&#xD;
synthesized by the reaction of various substituted chalcones with&#xD;
ethylacetoacetate. Some new N-(4-(3-aryl-acryloyl)phenyl)cyclopropane&#xD;
carboxamide were prepared by Claisen-Schmidt condensation&#xD;
method in presence of sodium hydroxide in ethanol solvent under&#xD;
stirring. The synthesized compounds were characterized by their&#xD;
spectral (IR, NMR, Mass) data and screened for their antimicrobial&#xD;
activities against Gram-positive and Gram-negative bacteria by using&#xD;
standard antimicrobial drugs.</summary>
    <dc:date>2019-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Synthesis, Characterization and in vitro Antimicrobial Evaluation of Pyrazole Based Oxothiazolidine Hybrids</title>
    <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/2194" />
    <author>
      <name>Sanghani, Yogesh J.</name>
    </author>
    <author>
      <name>Koradiya, Suresh B.</name>
    </author>
    <author>
      <name>Jilariya, Krushnakumar J.</name>
    </author>
    <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/2194</id>
    <updated>2025-01-01T10:58:27Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Synthesis, Characterization and in vitro Antimicrobial Evaluation of Pyrazole Based Oxothiazolidine Hybrids
Authors: Sanghani, Yogesh J.; Koradiya, Suresh B.; Jilariya, Krushnakumar J.
Abstract: In this work, pyrazole based oxothiazolidine hybrids, 4-{4-[2-(1-&#xD;
phenyl-3-(substituted)phenyl-1H-pyrazol-4-yl)-4-oxo-thiazolidin-3-&#xD;
yl]-phenyl}-morpholin-3-one (11a-l) were synthesized using molecular&#xD;
hybridization approach through Vilsmeier-Haack reaction. The titled&#xD;
compounds 11a-l were characterized by using elemental analysis, IR,&#xD;
1H NMR and mass spectral studies. The antibacterial activity of 11a-l&#xD;
was evaluated in vitro by agar cup plate method against B. cocous, B.&#xD;
subtillis, E. coli and P. vulgaris. The antifungal activity of compounds&#xD;
11a-l was evaluated in vitro by agar based disk diffusion method&#xD;
against A. niger. The results of antibacterial and antifungal evaluation&#xD;
were reported in terms of zone of inhibition measured in mm. The&#xD;
synthesized compounds 11a-l exhibited moderate to good antibacterial&#xD;
and antifungal potential. Compound 4-{4-[2-(1-phenyl-3-(2-methoxyphenyl)&#xD;
phenyl-1H-pyrazol-4-yl)-4-oxo-thiazolidin-3-yl]-phenyl}-&#xD;
morpholin-3-one (11h) emerged as a most potent antimicrobial agent&#xD;
displaying zone of inhibition 21, 20, 21, 24 and 20 mm against B.&#xD;
cocous, B. subtillis, E. coli, P. vulgaris and A. niger, respectively.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Steroid and fatty acid contents from  the leaves of Carica Papaya</title>
    <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/990" />
    <author>
      <name>Devmurari, Vishvraj V.</name>
    </author>
    <author>
      <name>Patel, Poojaben P.</name>
    </author>
    <author>
      <name>Jadeja, Rajeshreeba A.</name>
    </author>
    <author>
      <name>Bhadaniya, Cameykumari P.</name>
    </author>
    <author>
      <name>Aghara, Priti P.</name>
    </author>
    <author>
      <name>Patel, Anilkumar S.</name>
    </author>
    <author>
      <name>Tala, Satishkumar D.</name>
    </author>
    <author>
      <name>Savant, Mahesh M.</name>
    </author>
    <author>
      <name>Ladva, Kartik D.</name>
    </author>
    <author>
      <name>Nariya, Pankajkumar B.</name>
    </author>
    <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/990</id>
    <updated>2023-05-17T05:07:47Z</updated>
    <published>2021-06-30T00:00:00Z</published>
    <summary type="text">Title: Steroid and fatty acid contents from  the leaves of Carica Papaya
Authors: Devmurari, Vishvraj V.; Patel, Poojaben P.; Jadeja, Rajeshreeba A.; Bhadaniya, Cameykumari P.; Aghara, Priti P.; Patel, Anilkumar S.; Tala, Satishkumar D.; Savant, Mahesh M.; Ladva, Kartik D.; Nariya, Pankajkumar B.
Abstract: Aim: To extract and identify the non-polar entities from the leaves of Carica papaya, a plant used for medicinal purpose as folk medicine.&#xD;
Materials and methods: Petroleum ether extract of the Carica papaya leaves was used for this study. Saponification process and &#xD;
methylation process was performed to separate fatty acids and unsaponifiable matters. Phytochemical constituents were separated using &#xD;
chemical process and separated fractions were analyzed by thin layer chromatography (TLC) and gas chromatography coupled with &#xD;
mass spectroscopy (GC-MS).&#xD;
Results: The chemical composition of the steroids, triterpenoids and fatty acid methyl esters (FAMEs) in leaves of Carica papaya, &#xD;
which were analyzed by gas chromatography coupled with mass spectroscopy (GC-MS). A total of 15 fatty acid components were &#xD;
identified in saponifiable matter, from unsaponifiable portion 2 steroids (campesterol, β- or γ-sitosterol), 1 triterpene (squalene), and 1 &#xD;
diterpene (phytol) were identified.&#xD;
Conclusions: The results indicate that the extract is rich in non-polar compounds. In this study, GC-MS method is at the central focus &#xD;
for identification of these phytoconstituents. The current method can be used for direct analysis of non-polar entities of plant material.
Description: We are grateful to the Department of Chemistry, Atmiya &#xD;
University and Shri M. &amp; N. Virani Science College, Rajkot &#xD;
for providing laboratory and other required facilities.</summary>
    <dc:date>2021-06-30T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Isolation, identification and characterization of degradation  impurity of atorvastatin in fixed dose combination of atorvastatin  and ezetimibe</title>
    <link rel="alternate" href="http://10.9.150.37:8080/dspace//handle/atmiyauni/870" />
    <author>
      <name>Desai, Rajesh</name>
    </author>
    <author>
      <name>Koradiya, Suresh</name>
    </author>
    <id>http://10.9.150.37:8080/dspace//handle/atmiyauni/870</id>
    <updated>2023-05-08T04:33:59Z</updated>
    <published>2019-01-01T00:00:00Z</published>
    <summary type="text">Title: Isolation, identification and characterization of degradation  impurity of atorvastatin in fixed dose combination of atorvastatin  and ezetimibe
Authors: Desai, Rajesh; Koradiya, Suresh
Abstract: The objective of this study is to isolation and characterization of unknown degradation product of Atorvastatin &#xD;
calcium in combination formulation product with Ezetimibe by using modern techniques of separation and &#xD;
characterization. An unknown impurity is generating during a forced degradation study of Atorvastatin and &#xD;
Ezetimibe fixed-dose combination tablets. By using the gradient reversed-phase high-pressure liquid &#xD;
chromatographic method, unknown degradation impurity was detected and quantified in the range of 0.05% to 0.2% &#xD;
of Atorvastatin. The impurity was enriched by extreme oxidation degradation of Atorvastatin and isolated through &#xD;
preparative HPLC. The structure of the impurity was characterized by mass and NMR spectrum.</summary>
    <dc:date>2019-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

